CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Melanoma D008545 69 associated lipids
Leukemia D007938 74 associated lipids
Alzheimer Disease D000544 76 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Muhlfelder TW et al. Factors influencing the release of procoagulant-tissue factor activity from leukocytes. 1978 J. Lab. Clin. Med. pmid:659965
Sagone AL et al. Characteristics of the metabolic response of human monocytes to red cells sensitized with anti-D alloantibodies. 1981 J. Lab. Clin. Med. pmid:6790643
Harfenist EJ et al. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. 1981 J. Lab. Clin. Med. pmid:6783712
Fantone J et al. Biochemical quantitation of the chemotactic factor inactivator activity in human serum. 1979 J. Lab. Clin. Med. pmid:759526
Kitajima Y et al. Reorganization of keratin intermediate filaments by the drug-induced disruption of microfilaments in cultured human keratinocytes. 1986 J. Invest. Dermatol. pmid:2430025
Morioka S et al. Migrating keratinocytes express urokinase-type plasminogen activator. 1987 J. Invest. Dermatol. pmid:2435817
Glinski W et al. Reduced expression of surface receptors for synthetic N-formylated chemotactic oligopeptides by stimulated peripheral blood neutrophils in psoriasis. 1987 J. Invest. Dermatol. pmid:3668297
Novales RR The effect of the divalent cation ionophore A23187 on amphibian melanophores and iridophores. 1977 J. Invest. Dermatol. pmid:333033
Patel HP et al. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. 1984 J. Invest. Dermatol. pmid:6389716
Cowin AJ et al. Differential effect of wounding on actin and its associated proteins, paxillin and gelsolin, in fetal skin explants. 2003 J. Invest. Dermatol. pmid:12787143
Hönigsmann H et al. Immediate pigment darkening phenomenon. A reevaluation of its mechanisms. 1986 J. Invest. Dermatol. pmid:3772158
Iizuka H et al. Colchicine-induced alteration of hormone-stimulated cyclic AMP synthesis in pig skin (epidermis). 1984 J. Invest. Dermatol. pmid:6323587
Svitlik C and Marcus PI Interferon induction by viruses. XI. Early events in the induction process. 1984 J. Interferon Res. pmid:6209349
Balint E et al. Cytoskeletal modulation of plasma membrane events induced by interferon-alpha. 1992 J. Interferon Res. pmid:1331257
Bukholm G et al. Interferon-induced protein synthesis inhibits endocytosis of bacteria in epithelial cells. 1987 J. Interferon Res. pmid:3312425
Ritzenthaler JD and Roman J Interleukin-1beta gene transcription in U937 cells is modulated by type I collagen and cytoskeletal integrity via distinct signaling pathways. 2001 J. Interferon Cytokine Res. pmid:11244575
Mattila JT et al. Phagocytosis of the Lyme disease spirochete, Borrelia burgdorferi, by cells from the ticks, Ixodes scapularis and Dermacentor andersoni, infected with an endosymbiont, Rickettsia peacockii. 2007 J. Insect Sci. pmid:20331397
Yamamoto A et al. Cadmium stimulates glucose metabolism in rat adipocytes. 1986 J. Inorg. Biochem. pmid:3531403
Zimmerli W et al. The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. 1990 J. Infect. Dis. pmid:2153739
Galgiani JN et al. Leukocyte effects on the dimorphism of Coccidioides immitis. 1982 J. Infect. Dis. pmid:7086205
Brito GA et al. Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. 2002 J. Infect. Dis. pmid:12001047
Kan VL and Bennett JE Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. 1988 J. Infect. Dis. pmid:3042877
Peterson PK et al. Human peritoneal macrophage cytotoxicity mediated by cytophilic IgG. 1983 J. Infect. Dis. pmid:6655286
Benach JL et al. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. 1984 J. Infect. Dis. pmid:6386995
Zhang B et al. Penicillin G-induced microbicidal activity of endothelial cells cultured on gelfoam blocks. 1996 J. Infect. Dis. pmid:8896501
Sandberg G The sealed capillary migration technique and thymocyte migration in vitro. 1976 J. Immunol. Methods pmid:1085786
Verschueren H et al. Methods for computer assisted analysis of lymphoid cell shape and motility, including Fourier analysis of cell outlines. 1993 J. Immunol. Methods pmid:8335964
Ohara J et al. Purification of cytoplasts (enucleated cells) and karyoplasts (nuclei) from mouse splenic lymphocytes with cytochalasin-B. 1981 J. Immunol. Methods pmid:6169767
Lombard Y et al. A new method for studying the binding and ingestion of zymosan particles by macrophages. 1994 J. Immunol. Methods pmid:8083517
Palmblad J et al. The quantification of neutrophil orientation and migration under agarose--a new method for detecting directed and random movements. 1981 J. Immunol. Methods pmid:7252175
MacFarlane GD and Herzberg MC Concurrent estimation of the kinetics of adhesion and ingestion of Staphylococcus aureus by human polymorphonuclear leukocytes (PMNs). 1984 J. Immunol. Methods pmid:6420472
Giaimis J et al. A new and simple method for studying the binding and ingestion steps in the phagocytosis of yeasts. 1992 J. Immunol. Methods pmid:1383342
Mege JL et al. Study of cell deformability by a simple method. 1985 J. Immunol. Methods pmid:3928763
Haynes AP et al. A novel flow cytometric method for measuring protein digestion within the phagocytic vacuole of polymorphonuclear neutrophils. 1990 J. Immunol. Methods pmid:2273255
Sveum RJ et al. A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. 1986 J. Immunol. Methods pmid:3722828
Yoshinari K et al. Long-term production of human monoclonal antibodies by human-mouse heterohybridomas. 1995 J. Immunol. Methods pmid:7561144
Tanaka Y et al. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells. 1999 J. Immunol. pmid:10570313
Owen WF et al. Synthesis and release of leukotriene C4 by human eosinophils. 1987 J. Immunol. pmid:3025300
David JR et al. Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. 1977 J. Immunol. pmid:193993
Parker CW Pharmacologic modulation of release of arachidonic acid from human mononuclear cells and lymphocytes by mitogenic lectins. 1982 J. Immunol. pmid:6274957
Showell HJ et al. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. 1982 J. Immunol. pmid:6274960
Passwell JH et al. Increased prostaglandin production by human monocytes after membrane receptor activation. 1979 J. Immunol. pmid:448142
Shen Z et al. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. 1997 J. Immunol. pmid:9058806
van der Loo W et al. Cell differentiation in the presence of cytochalasin B: studies on the "switch" to IgG secretion after polyclonal B cell activation. 1979 J. Immunol. pmid:376713
Orange RP Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B-1. 1975 J. Immunol. pmid:46240
Lipsky PE and Rosenthal AS Macrophage-lymphocyte interaction: antigen-independent binding of guinea pig lymph node lymphocytes by macrophages. 1975 J. Immunol. pmid:50361
Boyle MD et al. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis. 1975 J. Immunol. pmid:50364
Rosenthal AS et al. Inhibition of macrophage-lymphocyte interaction by cytochalasin B during antigen recognition by T lymphocytes. 1975 J. Immunol. pmid:51878
Henson PM et al. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. 1978 J. Immunol. pmid:211165
Gemsa D et al. Induction of prostaglandin E release from macrophages by colchicine. 1980 J. Immunol. pmid:6243150
Bigby M et al. Phorbol myristate acetate-induced down-modulation of CD4 is dependent on calmodulin and intracellular calcium. 1990 J. Immunol. pmid:2109010
Katz P et al. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. 1982 J. Immunol. pmid:6890568
Ferguson TA et al. The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum. 1989 J. Immunol. pmid:2473113
Columbo M et al. The mechanism of mediator release from human basophils induced by platelet-activating factor. 1990 J. Immunol. pmid:1700998
Shaw JO et al. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). 1981 J. Immunol. pmid:6267133
Abo T et al. Selective phagocytosis of gram-positive bacteria and interleukin 1-like factor production by a subpopulation of large granular lymphocytes. 1986 J. Immunol. pmid:3514754
Brandt E et al. Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. 1992 J. Immunol. pmid:1323612
Norgauer J et al. Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils. 1991 J. Immunol. pmid:1988505
Tomhave ED et al. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. 1994 J. Immunol. pmid:8089498
Lander HM et al. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. 1993 J. Immunol. pmid:8432991
Becker EL and Showell HJ The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release. 1974 J. Immunol. pmid:4825785
Dahinden C and Fehr J Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation. 1983 J. Immunol. pmid:6294179
Weaver EA et al. Secretion of immunoglobulin A by human milk leukocytes initiated by surface membrane stimuli. 1984 J. Immunol. pmid:6690613
Kersey JH et al. Human T lymphocyte receptors for sheep erythrocytes: conditions for binding including inhibition by cytochalasin B. 1974 J. Immunol. pmid:4544364
Ferreri NR et al. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. 1986 J. Immunol. pmid:3009617
Greenberg PD and Bluestein HG Antigen recognition by primed T lymphocytes in vitro. I. Separation of recognitive and proliferative phases of antigen-induced T cell activation. 1978 J. Immunol. pmid:307572
Tiku K et al. Interleukin 1 production by human polymorphonuclear neutrophils. 1986 J. Immunol. pmid:3084639
Baly DL et al. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor. 1998 J. Immunol. pmid:9794430
Kammer GM et al. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton. 1983 J. Immunol. pmid:6600189
Joseph BS and Oldstone MB Antibody-induced redistribution of measles virus antigens on the cell surface. 1974 J. Immunol. pmid:4606230
Martínez-Lorenzo MJ et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. 1999 J. Immunol. pmid:10415024
Hoffman R et al. Effect of cytochalasin B on human lymphocyte responses to mitogens: time and concentration dependence. 1977 J. Immunol. pmid:850072
Williams JD et al. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine. 1986 J. Immunol. pmid:3001181
Petersen F et al. TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. 1996 J. Immunol. pmid:8596050
Gormus BJ et al. Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agents. 1980 J. Immunol. pmid:7373047
Kishimoto T et al. Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. 1975 J. Immunol. pmid:1080773
Goldstein IM and Weissmann G Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. 1974 J. Immunol. pmid:4473046
Yasaka T et al. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). 1982 J. Immunol. pmid:6278021
Epstein RL et al. Interaction of reovirus with cell surface receptors. III. Reovirus type 3 induces capping of viral receptors on murine lymphocytes. 1981 J. Immunol. pmid:6975296
Roberts RL and La Via MF Inhibition of antigen-induced B lymphocyte activation in vitro by cytochalasin B. 1976 J. Immunol. pmid:778260
Fletcher MP Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes. 1987 J. Immunol. pmid:3693900
Tenner AJ and Cooper NR Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. 1982 J. Immunol. pmid:6281333
Bender JG et al. Independent regulation of human neutrophil chemotactic receptors after activation. 1987 J. Immunol. pmid:2822801
Atkinson JP et al. Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures. 1977 J. Immunol. pmid:557509
Bauldry SA et al. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. 1991 J. Immunol. pmid:1846897
Norton JM and Munck A Glucose transport in murine macrophages: in vitro characterization of the monosaccharide transport system of the thioglycollate-elicited mouse peritoneal macrophage. 1980 J. Immunol. pmid:6991602
Mullmann TJ et al. Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. 1990 J. Immunol. pmid:2307846
Woodruff JJ et al. An in vitro model of lymphocyte homing. II. Membrane and cytoplasmic events involved in lymphocyte adherence to specialized high-endothelial venules of lymph nodes. 1977 J. Immunol. pmid:410878
Ziegler HK et al. Studies on the cytolytic activity of human lymphocytes. III. An analysis of requirements for K cell-target interaction. 1977 J. Immunol. pmid:410884
Cassatella MA et al. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. 1992 J. Immunol. pmid:1578146
Murakami S et al. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. 1994 J. Immunol. pmid:7506725
Müller H and Fehr J Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors. 1986 J. Immunol. pmid:3950412
Peacock JS and Barisas BG Photobleaching recovery studies of antigen-specific mouse lymphocyte stimulation by DNP-conjugated polymerized flagellin. 1981 J. Immunol. pmid:6167632
Henson PM et al. Intracellular control of human neutrophil secretion. II. Stimulus specificity of desensitization induced by six different soluble and particulate stimuli. 1981 J. Immunol. pmid:7019331
Zeiger RS and Colten HR Histaminase release from human eosinophils. 1977 J. Immunol. pmid:402420
Serhan CN et al. PGBX, a prostagandin derivative, mimics the action of the calcium ionophore A23187 on human neutrophils. 1980 J. Immunol. pmid:6253562
Grossi CE et al. Ontogeny of B cells in the chicken. II. Changing patterns of cytoplasmic IgM expression and of modulation requirements for surface IgM by anti-mu antibodies. 1977 J. Immunol. pmid:407304
Uzgiris EE et al. Oscillation of cell surface charge of human peripheral blood lymphocytes after stimulation with concanavalin A. 1982 J. Immunol. pmid:7199546
Abbas AK T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes. 1979 J. Immunol. pmid:114584
Moy JN et al. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. 1990 J. Immunol. pmid:2170521